Seine Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.12 M
as on 29-06-2024
- Paid Up Capital ₹ 0.12 M
as on 29-06-2024
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
About Seine Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.12 M and a paid-up capital of Rs 0.12 M, as per Ministry of Corporate Affairs (MCA) records.
Venkata Chittireddy, Naveen Kunchala, and Naveen Kotla serve as directors at the Company.
- CIN/LLPIN
U24110TG2020PTC143603
- Company No.
143603
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Sep 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Seine Pharma Private Limited offer?
Seine Pharma Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Pharma Ingredients & Raw Materials, API Intermediate, Antipyretic and Analgesic API, Blood System and Cardiovascular API, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Common Disease Medicines, Pharmaceutical Medicine.
Who are the key members and board of directors at Seine Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Chittireddy  | Director | 07-Sep-2020 | Current |
| Naveen Kunchala | Director | 07-Sep-2020 | Current |
| Naveen Kotla | Director | 07-Sep-2020 | Current |
Financial Performance of Seine Pharma.
Seine Pharma Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Seine Pharma?
In 2021, Seine Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Seine Pharma?
Seine Pharma has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Seine Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seine Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
